abstract |
A pharmaceutical composition comprising as active ingredient 5 - [[4- [3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl] methoxy] phenylmethyl] thiazolidine-2,4-dione or a pharmaceutically acceptable salt thereof, lactose , microcrystalline cellulose, magnesium stearate and / or talc and a method for its preparation. |